CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD. Govoni M, Bassi M, Girardello L, Lucci G, et al. Respir Res 2024;25:380.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Govoni M, Bassi M, Girardello L, Lucci G, et al. CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD. Respir Res 2024;25:380.
PMID: 39427187